Private company

SURGALIGN HOLDINGS, INC.

SURGALIGN HOLDINGS, INC. is an American orthopedic company, incorporated in Delaware.1 It is headquartered in Deerfield, Illinois.1

Last updated Oct 20, 2026.

Overview

  • IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies1
  • HeadquartersDeerfield, Illinois1
  • Incorporated inDE2
  • Business address520 Lake Cook Road, Suite 315, Deerfield, Il 600152
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

49.1%Gross margin3
-95.7%Operating margin3
-66.6%Net margin3
-9.4%Revenue growth, 20223
-$58.9MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue51¢$41.7M
  • Research and development19¢$15.7M
  • Other costs27¢$22.5M
  • Interest1¢$1.0M
  • Income tax1¢$1.0M

Out of $82.0M in revenue.3 The company lost money this year.

Financial statements

Revenue45673$82.0M in 2022−70% since 2016
0$100.0M$200.0M$300.0M2016: $276.0M$276.0M20162017: $280.3M$280.3M2017+2%2018: $92.1M$92.1M2018−67%2019: $117.4M$117.4M2019+27%2020: $101.7M$101.7M2020−13%2021: $90.5M$90.5M2021−11%2022: $82.0M$82.0M2022−9%
Gross profit45673$40.3M in 2022−70% since 2016
0$50.0M$100.0M$150.0M2016: $133.3M$133.3M20162017: $143.1M$143.1M2017+7%2018: $58.5M$58.5M2018−59%2019: $84.6M$84.6M2019+45%2020: $57.7M$57.7M2020−32%2021: $60.7M$60.7M2021+5%2022: $40.3M$40.3M2022−34%
Operating income45673-$78.5M in 2022+414% since 2016
-$300.0M-$200.0M-$100.0M0$100.0M2016: -$15.3M-$15.3M20162017: $29.3M$29.3M20172018: -$64.8M-$64.8M20182019: -$242.9M-$242.9M2019+275%2020: -$198.0M-$198.0M2020−18%2021: -$137.3M-$137.3M2021−31%2022: -$78.5M-$78.5M2022−43%
Net income45673-$54.6M in 2022+296% since 2016
-$300.0M-$200.0M-$100.0M0$100.0M2016: -$13.8M-$13.8M20162017: $6.9M$6.9M20172018: -$3.1M-$3.1M20182019: -$211.6M-$211.6M2019+6677%2020: -$33.8M-$33.8M2020−84%2021: -$84.7M-$84.7M2021+151%2022: -$54.6M-$54.6M2022−35%
Fiscal year2016201720182019202020212022
Revenue$276.0M4$280.3M5$92.1M6$117.4M7$101.7M7$90.5M3$82.0M3
Cost of revenue$142.7M4$137.3M5$33.6M6$32.8M7$44.0M7$29.8M3$41.7M3
Gross profit$133.3M4$143.1M5$58.5M6$84.6M7$57.7M7$60.7M3$40.3M3
Research and development$16.3M4$13.3M5$14.4M6$16.8M7$11.9M7$13.9M3$15.7M3
Selling, general and admin$116.7M4$115.0M5$98.2M6$135.4M6$124.4M6
Operating expenses$201.9M3$119.6M3
Operating income-$15.3M4$29.3M5-$64.8M6-$242.9M7-$198.0M7-$137.3M3-$78.5M3
Interest$1.7M4$3.2M5$2.8M5$12.6M5$03$1.0M3
Income before tax-$123.8M3-$55.6M3
Income tax-$3.2M4$19.3M5-$15.2M6$5.9M7-$3.5M7-$886.0K3-$1.0M3
Net income-$13.8M4$6.9M5-$3.1M6-$211.6M7-$33.8M7-$84.7M3-$54.6M3
Earnings per share-$0.304$0.055-$0.096-$3.027-$0.457-$20.723-$8.333
Earnings per share (diluted)-$0.304$0.055-$0.096-$3.027-$0.457-$20.723-$8.333
Shares (weighted, basic)4.1M shares36.6M shares3
Shares (weighted, diluted)4.1M shares36.6M shares3

Compare SURGALIGN HOLDINGS, INC. with another company

Corporate structure

SURGALIGN HOLDINGS, INC. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of SURGALIGN HOLDINGS, INC.

  • ARMISTICE CAPITAL, LLC Filed SC 13G/A on SURGALIGN HOLDINGS, INC., latest Feb 14, 2024 (2 filings since Feb 14, 2023)
  • DIMENSIONAL FUND ADVISORS LP Filed SC 13G/A on SURGALIGN HOLDINGS, INC., latest Feb 8, 2022
  • Krzysztof Siemionow Filed SC 13D on SURGALIGN HOLDINGS, INC., latest Feb 4, 2022
  • Pawel Lewicki Filed SC 13D/A on SURGALIGN HOLDINGS, INC., latest Feb 4, 2022
  • WELLINGTON TRUST Co N A Filed SC 13G/A on SURGALIGN HOLDINGS, INC., latest Feb 4, 2022
  • Wellington Management Company Filed SC 13G/A on SURGALIGN HOLDINGS, INC., latest Feb 4, 2022
  • Wellington Trust Company, National Association Multiple Common Trust Funds Trust, Micro Cap Equity Portfolio Filed SC 13G/A on SURGALIGN HOLDINGS, INC., latest Feb 4, 2022
  • SURGALIGN HOLDINGS, INC. Deerfield, Illinois

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What SURGALIGN HOLDINGS, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$2.1M3 Dec 31, 2022$945.0K3 Dec 31, 2021+117.7%
Operating-lease assets (leased space)$967.0K3 Dec 31, 2022$876.0K3 Dec 31, 2021+10.4%

Real estate and locations

ItemLatestA year beforeChange
Countries it operates in403 Dec 31, 2022507 Dec 31, 2021−20.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$16.3M3 Dec 31, 2022$51.3M3 Dec 31, 2021−68.2%

Inventory

ItemLatestA year beforeChange
Inventory, total$17.7M3 Dec 31, 2022$26.2M3 Dec 31, 2021−32.4%

Leadership

Who has led SURGALIGN HOLDINGS, INC., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Camille Farhat2019
  2. Terry Rich2020–2023

President

  1. Terry Rich2019–2023
  2. Olivier M. Visa2020

Chief financial officer

  1. M. Singer Jonathon2019–2021
  2. David Lyle2022–2023

Chief operating officer

  1. M. Singer Jonathon2020–2021
20202025
Board members and other officers (23)

Former names

  • RTI Surgical Holdings, Inc.Mar 8, 2019 to Jul 15, 20202
  • Bears Holding Sub, Inc.Dec 6, 2018 to Feb 7, 20192

Timeline

  1. Sep 29, 20238-K Bankruptcy or receivership; Change to shareholders' rights; Change of auditor41
  2. Aug 18, 20238-K Entered a material agreement; Completed an acquisition or sale42
  3. Aug 1, 20238-K Regulation FD disclosure; Other events43
  4. Jun 23, 20238-K Listing notice or transfer; Regulation FD disclosure44
  5. Jun 23, 20238-K Regulation FD disclosure45
  6. Jun 20, 20238-K Exit or restructuring costs; Executive or director change46
  7. Jun 20, 20238-K Entered a material agreement; Bankruptcy or receivership; Debt or obligation accelerated47
  8. Jun 15, 20238-K Executive or director change48
  9. Jun 9, 20238-K Listing notice or transfer; Other events49
  10. May 30, 20238-K Other events50
  11. May 22, 20238-K Ended a material agreement51
  12. May 11, 20238-K Results of operations52
  13. Jul 24, 2020New chief executive Terry Rich becomes CEO11
  14. Mar 8, 2019New chief executive Camille Farhat becomes CEO12

Calendar

When it reported results

  1. May 11, 2023Reported quarterly or annual results52
  2. Mar 30, 2023Reported quarterly or annual results53
  3. Mar 6, 2023Reported quarterly or annual results54
  4. Nov 2, 2022Reported quarterly or annual results55
  5. Aug 9, 2022Reported quarterly or annual results56
  6. May 10, 2022Reported quarterly or annual results57
  7. Mar 15, 2022Reported quarterly or annual results58
  8. Jan 18, 2022Reported quarterly or annual results59

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

146 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 42 major events, 60 insider forms, 8 large holders, 29 other. The latest 20:

  1. Feb 14, 2024SC 13G/A EDGAR
  2. Nov 13, 202315-12G EDGAR
  3. Oct 6, 2023EFFECT EDGAR
  4. Oct 6, 2023EFFECT EDGAR
  5. Oct 6, 2023EFFECT EDGAR
  6. Oct 2, 2023S-8 POS POST-EFFECTIVE AMENDMENT TO FORM S-8 EDGAR
  7. Oct 2, 2023S-8 POS POST-EFFECTIVE AMENDMENT TO FORM S-8 EDGAR
  8. Oct 2, 2023S-8 POS POST-EFFECTIVE AMENDMENT TO FORM S-8 EDGAR
  9. Oct 2, 2023POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 EDGAR
  10. Oct 2, 2023POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 EDGAR
  11. Oct 2, 2023POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-4 EDGAR
  12. Sep 29, 20238-K CURRENT REPORT EDGAR
  13. Sep 18, 20234 FORM 4 SUBMISSION EDGAR
  14. Sep 5, 20234 FORM 4 SUBMISSION EDGAR
  15. Aug 18, 20238-K EDGAR
  16. Aug 16, 20234 FORM 4 SUBMISSION EDGAR
  17. Aug 16, 20234 FORM 4 SUBMISSION EDGAR
  18. Aug 16, 20234 FORM 4 SUBMISSION EDGAR
  19. Aug 16, 20234 FORM 4 SUBMISSION EDGAR
  20. Aug 16, 20234 FORM 4 SUBMISSION EDGAR

The 146 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

3 open-market trades by officers, directors and large owners since October 2021: 3 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
May 18, 2022Lyle DavidChief Financial OfficerBuy19,000$5.26$99.9KForm 4
Feb 15, 2022Durall William ScottChief Commercial OfficerBuy217,391$0.46$100.0KForm 4
Feb 15, 2022Rich Terry M.President and CEOBuy434,784$0.46$200.0KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How SURGALIGN HOLDINGS, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARSURGALIGN HOLDINGS, INC.1
  • CIK0001760173
  • Employer ID (EIN)83-25406071
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address520 Lake Cook Road, Suite 315, Deerfield, IL 600151
  • Phone38641888881
  • Shares outstanding9,183,447 as of May 5, 202310
  • Public float$22.1M as of Jun 30, 20223
  • On EDGAR sinceDec 6, 20181
  • Filings405 in all: 4 (119), 8-K (94), 3 (29), DEFA14A (15), 4/A (14), SC 13G/A (14), 10-Q (13), SC 13G (11)1
    All 43 form types

    S-8 POS (9), CORRESP (7), 8-K/A (6), EFFECT (6), UPLOAD (6), SC 13D (5), 10-K (4), 424B5 (4), DEF 14A (4), NT 10-Q (4), SC 13D/A (4), SEC STAFF LETTER (4), 424B3 (3), POS AM (3), S-8 (3), 10-K/A (2), PRE 14A (2), S-3 (2), SD (2), 10-Q/A (1), 15-12G (1), 25-NSE (1), 3/A (1), 424B4 (1), 8-K12B (1), ARS (1), CT ORDER (1), DEFM14A (1), NT 10-K (1), PREM14A (1), S-1 (1), S-1/A (1), S-3/A (1), S-4 (1), S-4/A (1)

  • Latest filingsAnnual report (10-K) Mar 30, 2023
    Quarterly report (10-Q) May 11, 2023
    Proxy statement (DEF 14A) Apr 28, 2023
    Latest 8-K (8-K) Sep 29, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
    SEC EDGAROther events
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66